Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Janssen

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine|December 31, 1998
Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in ratsJ Booij, R J Knol, L Reneman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Evaluation method for krypton-81m reservoir administration systemsA G Janssen, F H van Weeren, J J de Goeij, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECTJ Booij, T G Hemelaar, J D Speelman, et al.
Radiology|August 30, 2001
Estrogen receptor status in primary breast cancer: iodine 123-labeled cis-11beta-methoxy-17alpha-iodovinyl estradiol scintigraphyR J Bennink, L J Rijks, G van Tienhoven, et al.
Nuclear Medicine and Biology|January 1, 1997
The Z-isomer of 11 beta-methoxy-17 alpha-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancerL J Rijks, G J Boer, E Endert, et al.
European Journal of Nuclear Medicine|March 7, 1998
Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transportersJ Booij, E Busemann Sokole, M G Stabin, et al.
Archives of Neurology|May 1, 1993
Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomographyE van Royen, N F Verhoeff, J D Speelman, et al.
European Journal of Nuclear Medicine|March 7, 1998
Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imagingL J Rijks, E Busemann Sokole, M G Stabin, et al.
European Journal of Nuclear Medicine|September 1, 1993
Dosimetry of iodine-123 iodobenzamide in healthy volunteersN P Verhoeff, E B Sokole, M Stabin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's diseaseG Tissingh, J Booij, P Bergmans, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine|December 31, 1998
Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in ratsJ Booij, R J Knol, L Reneman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Evaluation method for krypton-81m reservoir administration systemsA G Janssen, F H van Weeren, J J de Goeij, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECTJ Booij, T G Hemelaar, J D Speelman, et al.
Radiology|August 30, 2001
Estrogen receptor status in primary breast cancer: iodine 123-labeled cis-11beta-methoxy-17alpha-iodovinyl estradiol scintigraphyR J Bennink, L J Rijks, G van Tienhoven, et al.
Nuclear Medicine and Biology|January 1, 1997
The Z-isomer of 11 beta-methoxy-17 alpha-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancerL J Rijks, G J Boer, E Endert, et al.
European Journal of Nuclear Medicine|March 7, 1998
Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transportersJ Booij, E Busemann Sokole, M G Stabin, et al.
Archives of Neurology|May 1, 1993
Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomographyE van Royen, N F Verhoeff, J D Speelman, et al.
European Journal of Nuclear Medicine|March 7, 1998
Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imagingL J Rijks, E Busemann Sokole, M G Stabin, et al.
European Journal of Nuclear Medicine|September 1, 1993
Dosimetry of iodine-123 iodobenzamide in healthy volunteersN P Verhoeff, E B Sokole, M Stabin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's diseaseG Tissingh, J Booij, P Bergmans, et al.
Pageof 4